What makes us special

Trasis has announced the acquisition of the pharmaceutical production facility formerly operated by Mithra CDMO S.A. (in bankruptcy) in Flémalle, Belgium. This transaction enables Trasis to significantly expand its cleanroom and laboratory production capacities by repurposing high-performance, existing infrastructure.

For 30 years, the the Entrepreneur of the Year Award has been celebrating Walloon companies that innovate, grow, and push boundaries. This year, Trasis has the immense honour of being named the Entrepreneur of the Year. A major recognition that deeply moves us.

After over ten years of collaboration, Trasis formed a joint venture in China with Beijing PET Technology to strengthen its local presence and expand access to advanced radiopharmaceutical solutions.

Today, the Trasis Group employs 450 people worldwide, reinforcing its global support capacity.

The building was becoming too small, so Trasis expanded its building in Ans.

Trasis Inc. was established in Atlanta to strengthen distribution, logistics and service operations in the United States.

After three years of collaboration, Eras Labo joined the Trasis Group, strengthening their strategic partnership.

Trasis reaches 230 employee! More to come!

Dedicated to radiometal labelling in hospitals, EasyOne might well be the smallest commercial synthesizer worldwide.

Trasis reaches 50 employees.

Intended for the flexible production of small batches of synthesizer consumables, for early-stage trials on request of research customers. It has since then been extended to medium scale for routine productions.

Trasis prepares the technical part of the FDOPA application of a partnering company applying for their Marketing Authorization.

This scaled-down version of AllinOne is dedicated to simple processes. It is mainly used for radiometal labelling and target reprocessing.

After having demonstrated [F18]FDG synthesis on microchips at multicurie levels, Trasis launches its AllinOne synthesizer, a universal plateform to develop and produce any radiotracers for routine production as well as for R&D

The company’s ground-breaking Unidose, a dose dispenser, becomes the first Trasis product to be sold, soon followed by the “Quickfill” dispenser.

Morelle and Philippart establish Trasis to pursue innovation and develop their ideas.

Gauthier Philippart joins Coincidence Technologies in 1999. Two years later, General Electric aquires Coincidence Technology 

Jean-Luc Morelle designs the very first radio-synthesizer to combine high-yield synthesis and GMP and creates “Coincidence Technologies”